Cargando…

Multiomics single timepoint measurements to predict severe COVID-19

Detalles Bibliográficos
Autores principales:	Tegethoff, Sina A, Last, Katharina, Papan, Cihan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876578/ https://www.ncbi.nlm.nih.gov/pubmed/36707187 http://dx.doi.org/10.1016/S2589-7500(22)00251-5

Ejemplares similares

Multiomics single timepoint measurements to predict severe COVID-19 – Authors' reply
por: Garapati, Kishore, et al.
Publicado: (2023)

COVID-19: fighting the foe with Virchow
por: Papan, Cihan, et al.
Publicado: (2021)

Expression of TRAIL, IP-10, and CRP in children with suspected COVID-19 and real-life impact of a computational signature on clinical decision-making: a prospective cohort study
por: Fröhlich, Franziska, et al.
Publicado: (2023)

A global health perspective on SARS-CoV-2—hazards, disaster and hope
por: Meyer, Sascha, et al.
Publicado: (2020)

Update on Coagulase-Negative Staphylococci—What the Clinician Should Know
por: Michels, Ricarda, et al.
Publicado: (2021)

Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis
por: Qin, Yan, et al.
Publicado: (2023)

Single-Timepoint Snapshot of Hemoglobin: Is it Enough to Reflect the Dynamicity of Coronary Atherosclerosis?
por: Yang, Seokhun, et al.
Publicado: (2022)

Multiomic elucidation of a coding 99-mer repeat-expansion skeletal muscle disease
por: Ruggieri, Alessandra, et al.
Publicado: (2020)

Attitudes of primary care physicians towards antimicrobial stewardship and the impact of a multi-part training course – a pilot study
por: Last, Katharina, et al.
Publicado: (2023)

Single-Cell Multiomics: Multiple Measurements from Single Cells
por: Macaulay, Iain C., et al.
Publicado: (2017)

Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells
por: Mayeur, Sylvain, et al.
Publicado: (2023)

The experiences and attitudes of family caregivers of adults with intellectual and developmental disabilities at different timepoints in the COVID-19 pandemic
por: Tarzi, Gabriel, et al.
Publicado: (2023)

An immune-protein score combining TRAIL, IP-10 and CRP for predicting severe COVID-19 disease
por: Mastboim, Niv Samuel, et al.
Publicado: (2023)

Evaluation of the host-response biomarker interferon-γ-induced protein-10 in predicting SARS-CoV-2 infectiousness
por: Tegethoff, S.A., et al.
Publicado: (2023)

Human infections caused by Staphylococcus argenteus in Germany: genetic characterisation and clinical implications of novel species designation
por: Alhussein, Farah, et al.
Publicado: (2020)

Key correlates of exclusive breastfeeding at three timepoints: Evidence from Ethiopia
por: Yigletu, Seblewongel, et al.
Publicado: (2022)

Changes to Astrocyte-associated Protein Expression at Different Timepoints of Cuprizone Treatment
por: Frankle, Lana, et al.
Publicado: (2023)

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018)

An integrative multiomics analysis identifies putative causal genes for COVID-19 severity
por: Wu, Lang, et al.
Publicado: (2021)

Teaching Medical Microbiology With a Web-Based Course During the COVID-19 Pandemic: Retrospective Before-and-After Study
por: Papan, Cihan, et al.
Publicado: (2023)

Hypertension and severe COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment
por: Park, Elyse R, et al.
Publicado: (2022)

Mavrilimumab for severe COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Mavrilimumab for severe COVID-19
por: Pourhoseingholi, Mohamad Amin, et al.
Publicado: (2020)

Ruxolitinib and Severe COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Polymorphisms and Severity of COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study
por: Byeon, Seul Kee, et al.
Publicado: (2022)

ICU admission and mortality classifiers for COVID-19 patients based on subgroups of dynamically associated profiles across multiple timepoints
por: Pezoulas, Vasileios C., et al.
Publicado: (2022)

A three-timepoint network analysis of Covid-19’s impact on schizotypal traits, paranoia and mental health through loneliness
por: Wong, Keri Ka-Yee, et al.
Publicado: (2022)

Severe COVID-19 in an Infant with Severe Acute Malnutrition
por: Beniwal, Neetu, et al.
Publicado: (2021)

Sepsis in severe COVID-19 is rarely septic shock: a retrospective single-centre cohort study
por: Arina, Pietro, et al.
Publicado: (2021)

External validation of a prediction model for CPAP failure in COVID-19 patients with severe pneumonitis
por: Stokes, Victoria, et al.
Publicado: (2022)

Neuropsychological predictors of conversion from mild cognitive impairment to dementia at different timepoints
por: Quaranta, Davide, et al.
Publicado: (2023)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
por: Molinari, Paolo, et al.
Publicado: (2021)

Reply to: Hypertension and severe COVID-19
por: Shibata, Shigeru, et al.
Publicado: (2023)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Laine, Marc, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_62p107asfjiu4k89e9rbdisva9